Review
doi: 10.1056/NEJMra011295.
Strategies to improve long-term outcomes after renal transplantation
Affiliations
- PMID: 11856798
- DOI: 10.1056/NEJMra011295
Item in Clipboard
Review
Strategies to improve long-term outcomes after renal transplantation
N Engl J Med.
.
No abstract available
Comment in
-
Strategies to improve outcomes after renal transplantation.N Engl J Med. 2002 Jun 27;346(26):2089-92; author reply 2089-92. doi: 10.1056/NEJM200206273462616. N Engl J Med. 2002. PMID: 12087150 No abstract available.
-
Strategies to improve outcomes after renal transplantation.N Engl J Med. 2002 Jun 27;346(26):2089-92; author reply 2089-92. N Engl J Med. 2002. PMID: 12088020 No abstract available.
-
Strategies to improve outcomes after renal transplantation.N Engl J Med. 2002 Jun 27;346(26):2089-92; author reply 2089-92. N Engl J Med. 2002. PMID: 12088021 No abstract available.
-
Strategies to improve outcomes after renal transplantation.N Engl J Med. 2002 Jun 27;346(26):2089-92; author reply 2089-92. N Engl J Med. 2002. PMID: 12088022 No abstract available.
-
Strategies to improve outcomes after renal transplantation.N Engl J Med. 2002 Jun 27;346(26):2089-92; author reply 2089-92. N Engl J Med. 2002. PMID: 12088023 No abstract available.
Similar articles
-
Placebo-controlled study of a humanized anti-TAC monoclonal antibody in dual therapy for prevention of acute rejection after renal transplantation.Transplant Proc. 1998 Jun;30(4):1331-2. doi: 10.1016/s0041-1345(98)00264-4. Transplant Proc. 1998. PMID: 9636541 Clinical Trial. No abstract available.
-
Current concepts and perspectives of immunosuppression in organ transplantation.Langenbecks Arch Surg. 2007 Sep;392(5):511-23. doi: 10.1007/s00423-007-0188-z. Epub 2007 Apr 21. Langenbecks Arch Surg. 2007. PMID: 17450373 Review.
-
Daclizumab: novel biologic immunoprophylaxis for prevention of acute rejection in renal transplantation.Transplant Proc. 1999 Sep;31(6):2206-7. doi: 10.1016/s0041-1345(99)00307-3. Transplant Proc. 1999. PMID: 10500546 Clinical Trial. No abstract available.
-
Immunosuppressive treatment options in renal transplantation.Minerva Urol Nefrol. 2005 Sep;57(3):141-9. Minerva Urol Nefrol. 2005. PMID: 15986013 Review.
-
Balancing efficacy and toxicity in kidney-transplant immunosuppression.N Engl J Med. 2007 Dec 20;357(25):2625-7. doi: 10.1056/NEJMe078181. N Engl J Med. 2007. PMID: 18094383 No abstract available.
Cited by
-
Antiviral treatment for chronic hepatitis B in renal transplant patients.World J Hepatol. 2015 Feb 27;7(2):189-203. doi: 10.4254/wjh.v7.i2.189. World J Hepatol. 2015. PMID: 25729474 Free PMC article. Review.
-
Expression of bone morphogenetic proteins 4, 6 and 7 is downregulated in kidney allografts with interstitial fibrosis and tubular atrophy.Int Urol Nephrol. 2015 Jul;47(7):1219-29. doi: 10.1007/s11255-015-0993-1. Epub 2015 May 12. Int Urol Nephrol. 2015. PMID: 25962604
-
Healthcare professionals lack confidence and training in approaching advanced care planning discussions during renal inpatient admissions.Future Healthc J. 2022 Jul;9(Suppl 2):59. doi: 10.7861/fhj.9-2-s59. Future Healthc J. 2022. PMID: 36310971 Free PMC article. No abstract available.
-
Overview on urinary tract infection, bacterial agents, and antibiotic resistance pattern in renal transplant recipients.J Res Med Sci. 2021 Mar 31;26:26. doi: 10.4103/jrms.JRMS_286_18. eCollection 2021. J Res Med Sci. 2021. PMID: 34221055 Free PMC article. Review.
-
Evaluation of NAG, NGAL, and KIM-1 as Prognostic Markers of the Initial Evolution of Kidney Transplantation.Diagnostics (Basel). 2023 May 25;13(11):1843. doi: 10.3390/diagnostics13111843. Diagnostics (Basel). 2023. PMID: 37296695 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
